Related Experiment Video
Updated: Mar 23, 2026

03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
1.1K
About thymic carcinomas: challenges in diagnosis and management
Mouna Mlika1, Sadok Boudaya2, Emna Braham3
1Department of Pathology, Abderrahman Mami Hospital, Ariana, Tunisia mounamlika22@gmail.com.
Asian Cardiovascular & Thoracic Annals
|March 23, 2016
Summary
Thymic carcinomas are rare and aggressive tumors. This study highlights their challenging diagnosis, diverse subtypes, and poor prognosis, emphasizing the need for standardized treatment approaches.
Area of Science:
- Oncology
- Thoracic Surgery
Background:
- Thymic carcinomas are rare neoplasms of the thymus gland.
- Diagnosis is often challenging due to nonspecific symptoms and imaging findings.
Purpose of the Study:
- To report a 17-year experience with thymic carcinomas.
- To highlight diagnostic challenges and differential diagnoses.
- To underscore the poor outcomes associated with these rare tumors.
Main Methods:
- Retrospective analysis of 13 patients diagnosed with thymic carcinoma over 17 years.
- Review of clinical, radiological, and pathological data.
- Analysis of treatment modalities and patient follow-up.
Main Results:
- The study included 12 men and 1 woman, with a mean age of 37 years.
- Chest pain was the most frequent symptom; all presented with anterior mediastinal masses.
- Histological subtypes included squamous cell carcinoma, synovial sarcoma, adenocarcinoma, undifferentiated carcinoma, clear cell carcinoma, lymphoepithelioma-like carcinoma, atypical carcinoid tumor, and sarcomatoid carcinoma.
- Surgical resection was only possible in one patient post-neoadjuvant therapy.
- Mean survival was 13 months in the 6 patients with available follow-up data.
Conclusions:
- Thymic carcinomas exhibit aggressive behavior and poor prognoses.
- Despite diagnostic challenges, early recognition and standardized treatment are crucial.
- Further research is needed to improve outcomes for patients with thymic carcinoma.
Related Concept Videos
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K

